ART Drug Dosage Adjustment Using FSCII in Chinese HIV-infected Population

Trial Profile

ART Drug Dosage Adjustment Using FSCII in Chinese HIV-infected Population

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Jan 2017

At a glance

  • Drugs Efavirenz (Primary) ; Lamivudine (Primary) ; Tenofovir disoproxil fumarate (Primary)
  • Indications HIV infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 18 Jan 2017 Status changed from active, no longer recruiting to completed.
    • 12 Oct 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top